Literature DB >> 2284095

The c-ets-1 proto-oncogene has oncogenic activity and is positively autoregulated.

A Seth1, T S Papas.   

Abstract

The proto-oncogene ets-1 is a member of the ets family of genes that share homology with the viral oncogene, v-ets, of the avian leukemia virus E26. By using expression vectors, we demonstrate that the ets-1 gene transforms NIH3T3 cells and the ets-1 transfected cells form colonies in soft agar and induce tumors in nude mice. We have also determined that the ets-1 protein contains homology with the helix-loop-helix motif of the HLH family proteins, but lacks the basic domain upstream of helix I. Transfection of the NIH3T3 cells with ets-1 vectors results in the activation of the endogenous ets-1 gene. Using hybridization probes that can distinguish between transcripts from endogenous and exogenous templates, we show that the endogenous ets-1 gene is activated by the expression of the transfected exogenous ets-1. In contrast, the expression of transfected ets-2 has no effect on the endogenous ets-1 gene expression. The results indicate that the ets-1 proto-oncogene is positively autoregulated by its product.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2284095

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  46 in total

1.  Both TEL and AML-1 contribute repression domains to the t(12;21) fusion protein.

Authors:  R Fenrick; J M Amann; B Lutterbach; L Wang; J J Westendorf; J R Downing; S W Hiebert
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

2.  Different binding site requirements for binding and activation for the bipartite enhancer factor EF-1A.

Authors:  G M Bolwig; J T Bruder; P Hearing
Journal:  Nucleic Acids Res       Date:  1992-12-25       Impact factor: 16.971

3.  A domain shared by the Polycomb group proteins Scm and ph mediates heterotypic and homotypic interactions.

Authors:  A J Peterson; M Kyba; D Bornemann; K Morgan; H W Brock; J Simon
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

4.  ETS target genes: identification of egr1 as a target by RNA differential display and whole genome PCR techniques.

Authors:  L Robinson; A Panayiotakis; T S Papas; I Kola; A Seth
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

5.  Structure of the Ets-1 pointed domain and mitogen-activated protein kinase phosphorylation site.

Authors:  C M Slupsky; L N Gentile; L W Donaldson; C D Mackereth; J J Seidel; B J Graves; L P McIntosh
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

6.  The expression of a novel, epithelium-specific ets transcription factor is restricted to the most differentiated layers in the epidermis.

Authors:  J M Andreoli; S I Jang; E Chung; C M Coticchia; P M Steinert; N G Markova
Journal:  Nucleic Acids Res       Date:  1997-11-01       Impact factor: 16.971

7.  Implication of a multisubunit Ets-related transcription factor in synaptic expression of the nicotinic acetylcholine receptor.

Authors:  L Schaeffer; N Duclert; M Huchet-Dymanus; J P Changeux
Journal:  EMBO J       Date:  1998-06-01       Impact factor: 11.598

8.  The Ets1 transcription factor is widely expressed during murine embryo development and is associated with mesodermal cells involved in morphogenetic processes such as organ formation.

Authors:  I Kola; S Brookes; A R Green; R Garber; M Tymms; T S Papas; A Seth
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

Review 9.  Transcriptional control of the cell cycle in mammary gland development and tumorigenesis.

Authors:  Ricardo D Coletta; Paul Jedlicka; Arthur Gutierrez-Hartmann; Heide L Ford
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-01       Impact factor: 2.673

10.  Regulators of gene expression as biomarkers for prostate cancer.

Authors:  Stacey S Willard; Shahriar Koochekpour
Journal:  Am J Cancer Res       Date:  2012-11-20       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.